Senator Investment Group LP - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Senator Investment Group LP ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q2 2023$3,355,000
-24.0%
500,0000.0%0.15%
-37.3%
Q1 2023$4,415,000
-42.2%
500,000
-50.0%
0.24%
-64.9%
Q4 2022$7,640,000
+7.3%
1,000,0000.0%0.69%
+6.2%
Q3 2022$7,120,000
-12.0%
1,000,0000.0%0.65%
+11.7%
Q2 2022$8,090,000
-41.7%
1,000,0000.0%0.58%
+34.7%
Q1 2022$13,880,000
-50.5%
1,000,0000.0%0.43%
-20.7%
Q4 2021$28,060,000
-17.4%
1,000,0000.0%0.54%
-6.9%
Q3 2021$33,990,000
-16.8%
1,000,0000.0%0.58%
-25.0%
Q2 2021$40,860,000
+1.5%
1,000,0000.0%0.78%
-6.3%
Q1 2021$40,260,000
-45.5%
1,000,000
-20.0%
0.83%
-40.7%
Q4 2020$73,912,000
-13.1%
1,250,000
-28.6%
1.40%
-43.7%
Q3 2020$85,102,000
+6.6%
1,750,000
+6.1%
2.48%
-10.1%
Q2 2020$79,827,000
-15.2%
1,650,000
-51.3%
2.76%
-19.0%
Q1 2020$94,121,000
-38.5%
3,388,085
-33.7%
3.41%
-18.6%
Q4 2019$152,984,000
+4.7%
5,113,0850.0%4.19%
+14.3%
Q3 2019$146,145,000
-30.4%
5,113,0850.0%3.67%
-4.9%
Q2 2019$209,918,0005,113,0853.86%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders